Health
Alzheimer's Drug Trial Results Mixed
Biogen reported mixed results from a mid-stage clinical trial for an Alzheimer’s disease treatment targeting the protein tau.
Coverage timeline — 1 article
STAT News
Biogen reported mixed results from a mid-stage clinical trial investigating a treatment for Alzheimer’s disease that targets the protein tau
2026-05-14 13:44 UTC